Blog

Melanoma is an aggressive form of skin cancer that has historically posed significant challenges for patients and healthcare providers. In the UK, there are around 48 new cases of Melanoma per day, and is the 5th most common cancer. In recent years, clinical trials have driven progress in treating the disease, offering hope to patients […]

Bladder cancer research benefits from clinical trials to advance research, drug development and treatments. Crucial research and findings come from clinical trials that aid not only in treating those with the disease, but also in progressing screening processes to make easier and earlier diagnosis.  According to Cancer Research, there are around 10,500 new bladder cancer […]

Clinical trials have been a cornerstone of the medical field for decades, serving as a critical foundation for the development and advancement of treatments across a wide range of diseases and health conditions. Beyond establishing the safety and effectiveness of new treatments, clinical trials also play a vital role in exploring ways to enhance care, […]

Clinical trials are essential for advancing treatments for sarcoidosis, especially since no cure currently exists. With the cause of sarcoidosis still unknown, ongoing research remains critical to understanding and combating the disease. Simbec-Orion is a Clinical Research Organisation specialising in rare diseases and oncology, with almost five decades of experience in delivering clinical trial management […]

Clinical trials play a key role in advancing the understanding and treatment of testicular cancer. As one of the most treatable forms of cancer, testicular cancer has a high survival rate when detected early. They offer new explorations into medicines, therapies, and treatment combinations that may improve a patient’s outcome at all stages of the […]

Clinical trials play a crucial role in advancing treatments for Parkinson’s disease, especially as there is still no cure and much about the disease remains unknown. As the fastest-growing neurological condition worldwide, Parkinson’s will impact approximately 1 in 37 people in the UK over their lifetime, making continued research essential. With nearly five decades of […]

In 2021, Project Optimus was launched by the U.S. Food and Drug Administration’s (FDA) Oncology Center of Excellence (OCE) to help oncology drug developers target dose optimisation and guide selection processes. Here, we answer some of the most pressing questions developers may have about the initiative. 1. What is the aim of Project Optimus? The […]